Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.

PURPOSE Positron emission tomographic (PET) scanning provides a novel means of imaging malignancies. This prospective study was undertaken to evaluate PET scanning in detecting para-aortic nodal metastasis in patients with locally advanced cervical carcinoma and no evidence of extrapelvic disease before planned surgical staging lymphadenectomy. MATERIALS AND METHODS After 20 mCi of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) were administered intravenously, the abdomen and pelvis were scanned. Continuous bladder irrigation was used to reduce artifact. Patients were classified by the presence or absence of FDG uptake in the primary tumor and in pelvic or para-aortic nodes. Para-aortic node metastases were classified as present or absent according to a standardized staging procedure. Pelvic node metastases were similarly classified in a subset of patients who underwent pelvic node resection. RESULTS Thirty-two patients with stage IIB (n = 6), IIIB (n = 24), and IVA (n = 2) tumors were studied. Fluorodeoxyglucose was taken up by 91% of the cervical tumors. Six of eight patients with positive para-aortic node metastasis had PET scan evidence of para-aortic nodal metastasis. One of the two false-negatives had only one microscopic focus of metastatic cancer. In the para-aortic nodes, PET scanning had a sensitivity of 75%, a specificity of 92%, a positive predictive value of 75%, and a negative predictive value of 92%. Fluorodeoxyglucose para-aortic nodal uptake conferred a relative risk of 9.0 (95% confidence interval, 2.3 to 36.0) for para-aortic nodal metastasis. All 10 of 17 patients with metastasis were predicted by PET scanning (P < .001); five of these patients had abnormalities on computed tomographic scans. CONCLUSION Cervical cancers have a high avidity for FDG. The use of PET-FDG scanning accurately predicts both the presence and absence of pelvic and para-aortic nodal metastatic disease.

[1]  L. Adler,et al.  Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis. , 1997, Journal of nuclear medicine technology.

[2]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[3]  E Abemayor,et al.  Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy , 1992, The Laryngoscope.

[4]  L. Twiggs,et al.  Pretreatment surgical staging of patients with cervical carcinoma , 1998, Cancer.

[5]  M. Piver,et al.  Para‐aortic lymphadenectomy, aortic node biopsy, and aortic lymphangiography in staging patients with advanced cervical cancer , 1973, Cancer.

[6]  L. Lagasse,et al.  The Operative Evaluation of Patients With Cervical Carcinoma by an Extraperitoneal Approach , 1977, Obstetrics and gynecology.

[7]  G. Jordan,et al.  Extraperitoneal lymph node dissections with use of a midline incision in patients with female genital cancer. , 1986, American journal of obstetrics and gynecology.

[8]  S. Pendlebury,et al.  Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. , 1993, International journal of radiation oncology, biology, physics.

[9]  J. Sorosky,et al.  Extended‐field radiation therapy for carcinoma of the cervix , 1990, Cancer.

[10]  P. Silverman,et al.  Computed Tomography in Evaluation of Extrapelvic Lymphadenopathy in Carcinoma of the Cervix , 1985, Obstetrics and gynecology.

[11]  S. Jani,et al.  Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. , 1992, International journal of radiation oncology, biology, physics.

[12]  Y. Yonekura,et al.  Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. , 1995, Radiology.

[13]  L. Adler,et al.  Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. , 1997, Radiology.

[14]  H. Shingleton,et al.  Cancer of the cervix , 1995 .

[15]  J. Read,et al.  The value of lymphoscintigraphy, lymphangiography and computer tomography scanning in the preoperative assessment of lymph nodes involved by pelvic malignant conditions , 1987, Surgery, gynecology & obstetrics.

[16]  D M Parkin,et al.  Estimates of the worldwide frequency of sixteen major cancers in 1980 , 1988, International journal of cancer.

[17]  P. Disaia,et al.  Carcinoma of the cervix treated with radiation therapy I. A multi‐variate analysis of prognostic variables in the gynecologic oncology group , 1991, Cancer.

[18]  R. Brookland,et al.  Para-aortic nodal metastases in early cervical carcinoma: long-term survival following extended-field radiotherapy. , 1983, Gynecologic oncology.

[19]  R. Brown,et al.  Accuracy of Lymphangiography in the Diagnosis of Paraaortic Lymph Node Metastases from Carcinoma of the Cervix , 1979, Obstetrics and gynecology.

[20]  M Schwaiger,et al.  Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  B. Bundy,et al.  Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis--a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.

[22]  D. Delbeke,et al.  Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. , 1996, Chest.

[23]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.